Neonatal antecedents for cerebral palsy in extremely preterm babies and interaction with maternal factors

Uyen Tran1, Peter H Gray, Michael J O'Callaghan

  • 1Developmental Paediatrics and Rehabilitation, University of Queensland, Mater Children's Hospital, South Brisbane, Queensland, Australia.

Insights

Periventricular leukomalacia (PVL) is the strongest predictor of cerebral palsy (CP) in extremely preterm infants. Antenatal factors do not appear to influence this risk, highlighting the importance of neonatal care.

Area of Science:

  • Neonatology
  • Neuroscience
  • Developmental Pediatrics

Background:

  • Preterm delivery significantly elevates the risk of cerebral palsy (CP).
  • Infants born before 28 weeks' gestation face the highest risk.
  • Identifying specific risk factors is crucial for targeted interventions.

Purpose of the Study:

  • To pinpoint significant neonatal risk factors for cerebral palsy (CP).
  • To investigate interactions between antenatal and neonatal risk factors.
  • Focusing on extremely preterm infants born at or before 27 weeks' gestation.

Main Methods:

  • A nested case-control study design was employed.
  • Infants born between 1989-1996 at 24-27 weeks' gestation were analyzed.
  • Matched analyses and logistic regression examined neonatal variables and factor interactions.

Main Results:

  • Key neonatal risk factors for CP included patent ductus arteriosus, peri-intraventricular hemorrhage, ventricular dilatation, periventricular leukomalacia (PVL), and home oxygen requirement.
  • Independent predictors were ventricular dilatation (OR 7.3), PVL (OR 29.8), and home oxygen use (OR 3.4).
  • No significant interactions were found between antenatal factors (e.g., antenatal steroids, intrauterine growth restriction) and neonatal risk factors.

Conclusions:

  • Periventricular leukomalacia (PVL) is the most potent independent predictor of CP in extremely preterm infants (≤27 weeks' gestation).
  • The influence of antenatal factors on PVL as a predictor of CP appears minimal.
  • This underscores the critical role of neonatal management in mitigating CP risk.
Abstract